首页> 外文期刊>Asian spine journal. >An Evaluation of the Effectiveness of Hyaluronidase in the Selective Nerve Root Block of Radiculopathy: A Double Blind, Controlled Clinical Trial
【24h】

An Evaluation of the Effectiveness of Hyaluronidase in the Selective Nerve Root Block of Radiculopathy: A Double Blind, Controlled Clinical Trial

机译:透明质酸酶在神经根病选择性神经根阻滞中的有效性评估:双盲对照临床试验

获取原文
           

摘要

Study Design Prospective, double-blind, randomized controlled trial. Purpose To determine the ability of hyaluronidase to provide longer lasting pain relief and functional improvement in patients with lumbar radiculopathy. Overview of Literature Selective nerve root block (SNRB) is a good treatment option in lumbar radiculopathy. We studied the effectiveness of hyaluronidase when added to the traditional SNRB regimen. Methods A sample size of 126 patients per group was necessary. A sample of 252 patients who underwent an injection procedure with or without hyaluronidase due to radiculopathy was included in this study. The patients were randomly divided into two groups: the control (C) group and the hyaluronidase (H) group. After SNRB due to radiculopathy, the visual analog scale (VAS) was compared at 2, 4, 6, 8, and 12 weeks between the two groups, and the Oswestry disability index (ODI) was compared at 12 weeks between the two groups. Results Both groups seemed to have general improvement in VAS, but in C group, the VAS was higher than the H group 2 and 4 weeks after the surgery, and the difference in time-group change between 2 groups was statistically significant ( p 0.05). Conclusions The rebound pain (the re-occurrence of pain within 2-4 weeks after injection) that occurs within 2-4 weeks after the injection of the routine regimen can be reduced when hyaluronidase is added to the routine SNRB regimen.
机译:研究设计前瞻性,双盲,随机对照试验。目的确定透明质酸酶为腰椎神经根病患者提供更持久的疼痛缓解和功能改善的能力。文献概述选择性神经根阻滞(SNRB)是腰椎神经根病的一种很好的治疗选择。我们研究了将透明质酸酶添加到传统SNRB方案中的有效性。方法每组126名患者的样本量是必要的。这项研究包括252例因神经根病而接受注射或不注射透明质酸酶的患者的样本。将患者随机分为两组:对照组(C)和透明质酸酶(H)组。在因神经根病而引起的SNRB后,比较两组之间在第2、4、6、8和12周时的视觉模拟量表(VAS),并比较两组在第12周时的Oswestry残疾指数(ODI)。结果两组患者的VAS似乎都有总体改善,但在C组,术后2周和4周VAS高于H组,两组之间的时间组变化差异具有统计学意义(p 0.05)。 。结论在常规SNRB方案中加入透明质酸酶可以减少常规方案注射后2-4周内发生的反弹痛(注射后2-4周内再次出现疼痛)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号